EP2227296
COMBINATION OF ANTI-CTLA4 ANTIBODY WITH TUBULIN MODULATING AGENTS FOR THE TREATMENT OF PROLIFERATIVE DISEASES
Status:
EP einkaleyfi: Þýðing ekki lögð innEP appl. date:
7.1.2009EP published:
25.11.2015EP application number:
09701364.3
EPO information:
European Patent Register
Max expiry date:
6.1.2029
Title:
COMBINATION OF ANTI-CTLA4 ANTIBODY WITH TUBULIN MODULATING AGENTS FOR THE TREATMENT OF PROLIFERATIVE DISEASES
Timeline
Today
7.1.2009EP application
25.11.2015EP Publication
Owner
Name:
Bristol-Myers Squibb CompanyAddress:
Route 206 and Province Line Road, 08543, Princeton, NJ, US
Inventor
Name:
JURE-KUNKEL, MariaAddress:
Princeton, NJ, US
Priority
Number:
19778 PDate:
8.1.2008Country:
US
Number:
56957 PDate:
29.5.2008Country:
US
Classification
Categories:
A61P 35/00, A61K 31/385, A61K 45/06, A61K 39/395